Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden

Gastroenterology

Volumn 150, Issue 7, 2016, Pages 1599-1608

  Younossi, Zobair ^a,b   Park, Haesuk ^c   Henry, Linda ^b   Adeyemi, Ayoade ^c   Stepanova, Maria ^d  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d Center for Outcomes Research in Liver Diseases   (United States)

Author keywords

Liver; Morbidity; Outcome; Pancreatic

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COST CONTROL; DEPRESSION; ECONOMIC ASPECT; END STAGE RENAL DISEASE; FATIGUE; FOLLOW UP; HEALTH CARE COST; HEPATITIS C; HUMAN; LICHEN PLANUS; LYMPHOMA; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PORPHYRIA CUTANEA TARDA; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SJOEGREN SYNDROME; SYSTEMATIC REVIEW; ADULT; ARTHRITIS, RHEUMATOID; CHRONIC HEPATITIS C; COMPLICATION; COST OF ILLNESS; CRYOGLOBULINEMIA; DIABETES MELLITUS, TYPE 2; ECONOMICS; FEMALE; HEPACIVIRUS; KIDNEY FAILURE, CHRONIC; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; SJOGREN'S SYNDROME; VIROLOGY;

ADULT; ARTHRITIS, RHEUMATOID; COST OF ILLNESS; CRYOGLOBULINEMIA; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; KIDNEY FAILURE, CHRONIC; LICHEN PLANUS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PORPHYRIA CUTANEA TARDA; PREVALENCE; QUALITY OF LIFE; SJOGREN'S SYNDROME;

EID: 84964621673     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.02.039     Document Type: Article

References (30)

1. B. Hajarizadeh, J. Grebely, and G.J. Dore Epidemiology and natural history of HCV infection Nat Rev Gastroenterol Hepatol 10 2013 553 562
2. N. Leone, and M. Rizzetto Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma Minerva Gastroenterol Dietol 51 2005 31 46
3. H.B. El-Serag, H. Hampel, C. Yeh, and et al. Extrahepatic manifestations of hepatitis C among United States male veterans Hepatology 36 2002 1439 1445
4. P. Cacoub, C. Renou, E. Rosenthal, and et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C Medicine (Baltimore) 79 2000 47 56
5. B. Basseri, D. Yamini, G. Chee, and et al. Comorbidities associated with the increasing burden of hepatitis C infection Liver Int 30 2010 1012 1018
6. Z. Cheng, B. Zhou, X. Shi, and et al. Extrahepatic manifestations of chronic hepatitis C virus infection: 297 cases from a tertiary medical center in Beijing, China Chin Med J (Engl) 127 2014 1206 1210
7. J. Rivera, A. Garcia-Monforte, and J.M. Núñez-Cortés Extrahepatic symptoms as presenting manifestaions of hepatitis C virus infection Rheumatol Int 5 1999 268 272
8. Z.M. Younossi, F. Kanwal, S. Saab, and et al. The impact of hepatitis C burden: an evidence-based approach Aliment Pharmacol Ther 39 2014 518 531
9. S. Petta, M. Maida, F.S. Macaluso, and et al. Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies Gastroenterology 150 2016 145 155.e4
10. J. Kallman, M.M. O'Neil, B. Larive, and et al. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection Dig Dis Sci 52 2007 2531 2539
11. D. Zalai, M. Sherman, K. McShane, and et al. The importance of fatigue cognitions in chronic hepatitis C infection J Psychosom Res 78 2015 193 198
12. T. Poynard, P. Cacoub, V. Ratziu, and et al. Fatigue in patients with chronic hepatitis C J Viral Hepat 9 2002 295 303
13. L.B. Krupp, N.G. LaRocca, J. Muir-Nash, and et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus Arch Neurol 46 1989 1121 1123
14. J.S. McCombs, Y. Yuan, J. Shin, and et al. Economic burden associated with patients diagnosed with hepatitis C Clin Ther 33 2011 1268 1280
15. H. Nyalakonda, and N.S. Utay A new era of therapy for hepatitis C virus infection Curr Opin Infect Dis 28 2015 471 478
16. Z.M. Younossi, M.E. Singer, H.M. Mir, and et al. Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients J Hepatol 60 2014 530 537
17. Z.M. Younossi, H. Park, S. Saab, and et al. Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection Aliment Pharmacol Ther 41 2015 544 563
18. D. Moher, A. Liberati, J. Tetzlaff, and et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement J Clin Epidemiol 62 2009 1006 1012
19. K. Rosa, M. Fu, L. Gilles, and et al. Validation of the Fatigue Severity Scale in chronic hepatitis C Health Qual Life Outcomes 12 2014 90
20. Oxford Centre for Evidence-based Medicine-Levels of Evidence (March 2009). Available at: http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/. Accessed July 31, 2015.
21. J.P.T. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
22. S.G. Thompson, and J.P.T. Higgins How should meta-regression analyses be undertaken and interpreted? Stat Med 21 2002 1559 1573
23. P. Macaskill, S.D. Walter, and L. Irwig A comparison of methods to detect publication bias in meta-analysis Stat Med 20 2001 641 654
24. Drug Pricing Policies. Available at: http://www.fdbhealth.com/policies/drug-pricing-policy/. Accessed July 31, 2015.
25. CPI Detailed Report-Data for December 2014. Available at: http://www.bls.gov/cpi/cpid1412.pdf. Accessed July 31, 2015.
26. H. Park, A. Adeyemi, L. Henry, and et al. A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection J Viral Hepat 22 2015 897 905
27. D.A. Mrazek, J.C. Hornberger, C.A. Altar, and et al. A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013 Psychiatr Serv 65 2014 977 987
28. A.A. Dan, C. Crone, T.N. Wise, and et al. Anger experiences among hepatitis C patients: relationship to depressive symptoms and health-related quality of life Psychosomatics 48 2007 223 229
29. Z.M. Younossi, M. Stepanova, F. Nader, and et al. The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life Aliment Pharmacol Ther 42 2015 286 295
30. Z.M. Younossi, Y. Jiang, N.J. Smith, and et al. Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: insights from a work productivity economic model from the United States Hepatology 61 2015 1471 1478